Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

70 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Completed

A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer

NCT02874664

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
View all 15 locations
View Trial Details
Completed

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

NCT00445198

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Site Reference ID/Investigator# 13605 Peoria, Arizona, United States
  • Site Reference ID/Investigator# 5261 Phoenix, Arizona, United States
  • Site Reference ID/Investigator# 11942 Los Angeles, California, United States
  • Site Reference ID/Investigator# 4718 Sacramento, California, United States
View all 18 locations
View Trial Details
Completed

A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide

NCT00759824

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium
  • Department of Pneumology CHU Charleroi Charleroi, Belgium
  • Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium
  • Hôpital Ambroise Paré Mons, Belgium
View Trial Details
Completed

A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

NCT00927875

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Local Institution East Bentleigh, Victoria, Australia
  • Local Institution Edmonton, Alberta, Canada
  • Local Institution Ottawa, Ontario, Canada
View Trial Details
Completed

LBH Phase II in Small Cell Lung Cancer (SCLC)

NCT01222936

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Klinik für Onkologie und Haematologie Frankfurt am Main, Germany
  • Klinikum Kassel Innere Medizin Kassel, Germany
  • Azienda Ospedaliera "S. G. Moscati" Avellino, AV, Italy
  • Istituto Nazionale Ricerca sul Cancro Genova, GE, Italy
View Trial Details
Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions
Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations
  • Arizona Cancer Center Tuscon, Arizona, United States
  • Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States
  • H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States
  • Nevada Cancer Institute Sparks, Nevada, United States
View Trial Details
Completed

Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer

NCT00143455

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Pfizer Investigational Site Wels, Austria
  • Pfizer Investigational Site Ghent, Belgium
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Liège, Belgium
View all 67 locations
View Trial Details

Related conditions